Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 14Unknown 6Recruiting 3Not yet recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Inositol × Clear all
NCT04881851 2025-04-16

IALA

Universita di Verona

Phase NA Terminated
76 enrolled

Polycystic Ovary Syndrome

NCT04306692 2022-12-21

Myo-inositol Versus Clomiphene Citrate in PCOS

University Hospital, Ghent

Phase 4 Terminated
12 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡